Life-Science Panorama

A Journal for Industry Executives

Brought to you by

October 27th, 2010

Research Addresses Challenges in the Globalization of Life Science Products

Global Supply Chain Visibility, Control & Collaboration; Regulatory Necessity, Business Imperative  

The dynamics of the Global Supply Chain are driving the Life Science ecosystem to seek innovative approaches which improve product safety while at the same time reducing costs and risks. To attain the sustained benefits of globalization, the Life Science ecosystem must implement a new paradigm to manage Global Supply Chains. This was a key finding of a major study of Pharmaceutical Drug, Medical Device and Bio-Pharmaceutical Industry Executives released today by the analyst and strategic advisory firm Axendia, Inc. 

 

Life Science Stakeholders must implement strategies which capitalize on the benefits of globalization, while proactively reducing and controlling risks.  This calls for changing the business, technology and regulatory models traditionally used by the Industry.

To this end, the research report recommends the Life Science ecosystem implement:

  • On-Demand-Visibility
  • Control Over the Global Supply Network
  • Collaboration Strategies

The complete findings of this research study are available today in a new report entitled, “Global Supply Chain Visibility, Control & Collaboration: Business Imperative, Regulatory Necessity”.

 

Read the Research Alert 

 

Request a copy of the Report

 

For more information about this report visit the research home page at: http://lsp.axendia.com/global-supply-chain/

October 12th, 2010

Webcast Previews Life Science Global Supply Chain Research Report Findings

Join us on Wednesday, October 13, 2010  for a preview of key findings from Axendia’s upcoming research report. The report reveals the need for a new paradigm for Global Supply Chains in Life Sciences. Globalization and Outsourcing dynamics are driving the Life Science ecosystem to seek innovative approaches, which improve product safety for enhanced clinical outcomes while at the same time reducing costs and risks, all while ensuring compliance with all applicable regulatory requirements.

To attain the sustained benefits of Global Supply Chains, Brand Owners must implement strategies, which capitalize on the benefits of globalization and outsourcing while proactively reducing and controlling risks. This calls for changing the business, technology and regulatory models traditionally used in the industry.

Join Axendia’s Daniel R. Matlis and Camstar’s Karim Lokas on Wednesday, October 13, 2010 for this webcast and get a preview of key findings from Axendia’s upcoming research report.

To register click on this link

|